Sevirumab Biosimilar - Research Grade

In stock
Only %1 left
SKU
ICH5858
Add to Compare
$710.00 - $6,900.00
Delivery Time : 4 weeks

Sevirumab Biosimilar - Research Grade

Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
HCMVï؟½
Concentration
5mg/ml
Isotype
IgG1 - kappa
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Shipping Conditions
Blue ice
Background
Human cytomegalovirus (HCMV) is a widespread herpesvirus and an important subject of antiviral and transplant-immunology research. The reagent here is a research-grade, unconjugated analog of sevirumab, a recombinant monoclonal antibody recognizing HCMV, intended for research use only. It is produced to in vivo standards with low endotoxin and offered in scalable milligram to gram quantities to support high-throughput study. Suitable applications include viral neutralization functional assays, in vitro binding and infectivity screens, and in vivo models examining cytomegalovirus infection and immune control. Batch consistency and ready availability make it a steady reagent for high-demand laboratories.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review
You're reviewing:Sevirumab Biosimilar - Research Grade
Your Rating
Back to Top